Tag: Vaccine
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Characteristics of the Participants Figure 1. Figure 1. Enrollment, Randomization, and Analysis Populations. The data-cutoff date for the primary vaccine efficacy analysis was August 20, 2021. Of the 25,170 participants who were recruited, 24,141 underwent randomization in the intention-to-treat population. These participants had no virologic evidence of Covid-19 before receiving the trial injection. The safety
Researchers develop online guide to help family medicine doctors discuss vaccine hesitancy with patients
ANN ARBOR, Mich., April 25, 2022 /PRNewswire/ — A team of public health specialists from the University of Calgary School of Public Policy has developed an interactive, web-based guide to help family doctors better speak to a wide range of patient concerns related to the COVID-19 vaccine. Working with primary care physicians, an action research
Six African countries to receive mRNA vaccine technology | Health And Beauty
BRUSSELS (AP) — The first African countries selected to receive the technology necessary to produce mRNA vaccines against COVID-19 are Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia, a summit meeting of European Union and African Union nations heard on Friday. The six countries have been chosen to build vaccine production factories as part of
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19
Our study showed that receipt of the BNT162b2 vaccine in patients who had recovered from Covid-19 was associated with substantially lower reinfection rates. These results are consistent with data from studies that have shown strong immunologic responses to vaccination in previously infected persons.11,19 Although vaccine effectiveness was lower among patients who were 65 years of
Djokovic could play in France under latest vaccine rules | Health and Fitness
FILE – Serbia’s Novak Djokovic kisses the cup after defeating Stefanos Tsitsipas of Greece during their final match of the French Open tennis tournament at the Roland Garros stadium Sunday, June 13, 2021 in Paris. Top-ranked player Novak Djokovic could be allowed to defend his French
BNT162b2 Vaccine Booster and Mortality Due to Covid-19
Study Design The study period started on August 6, 2021, which was 7 days after the approval of the booster for use in persons 60 years of age or older in Israel. The study period ended on September 29, 2021, which was the last date for which data regarding confirmed deaths due to Covid-19 were
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents
To the Editor: The B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as the dominant strain circulating in many regions worldwide. The BNT162b2 mRNA vaccine against coronavirus disease 2019 (Covid-19) was found to be effective in preventing infection with the delta variant in a recent observational study,1 but other reports
Michigan Medicine Nurses not mandated to get COVID vaccine
Last December, the Michigan Nurses Association voted to ratify a one-year extension to their previous collective bargaining agreement with Michigan Medicine. The agreement, which included a stipulation that nurses are not required to be vaccinated against COVID-19, covers all 6,200 nurses in the University of Michigan Professional Nurse Council Independent Union and will expire in